Jean-Marc Bachaud
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jean-Marc Bachaud has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Anne-Laure Fize
Pôle Hospitalo-Universitaire en Cancérologie, Cancer Pharmacology of Toulouse-Oncopole and Region (Work Package 4 Research Program), Institut Universitaire du Cancer de Toulouse-Oncopole, Université Paul Sabatier Toulouse III, Toulouse, France
2 shared publications - Charlotte Vaysse
Département de chirurgie oncologique, CHU de Toulouse, institut universitaire du cancer de Toulouse-Oncopole, Toulouse, France
2 shared publications - Elie Serrano
Faculté de Médecine, Université Paul Sabatier Toulouse III, Toulouse, France
2 shared publications - Elodie Chantalat
Department of Gynecological Surgery, CHU Rangueil, Toulouse, France
2 shared publications - Fabien Despas
Service de Pharmacologie Médicale et Clinique, Centre Hospitalier Universitaire de Toulouse, 31000, Toulouse, France.
2 shared publications - Louise Morineau
Pôle Hospitalo-Universitaire en Cancérologie, Cancer Pharmacology of Toulouse-Oncopole and Region (Work Package 4 Research Program), Institut Universitaire du Cancer de Toulouse-Oncopole, Université Paul Sabatier Toulouse III, Toulouse, France
2 shared publications
Latest Publications
- Open Access
- 5 March 2018
- Published by JMIR Publications Inc. in JMIR Medical Education
- Vol. 4 (1) , e6
The Impact of a Small Private Online Course as a New Approach to Teaching Oncology: Development and Evaluation
A New Peer-Reviewed Journal with Focus on Technology, Innovation and Openess in Medical Education
- 5 March 2018
- Published by JMIR Publications Inc. in JMIR Medical Education
- Vol. 4 (1) , e6
Open AccessThe Impact of a Small Private Online Course as a New Approach to Teaching Oncology: Development and Evaluation
A New Peer-Reviewed Journal with Focus on Technology, Innovation and Openess in Medical Education
- Open Access
- 16 October 2017
- Published by JMIR Publications Inc.
- Vol. 4 (1) , e6
The Impact of a Small Private Online Course as a New Approach to Teaching Oncology: Development and Evaluation
A New Peer-Reviewed Journal with Focus on Technology, Innovation and Openess in Medical Education
- 16 October 2017
- Published by JMIR Publications Inc.
- Vol. 4 (1) , e6
Open AccessThe Impact of a Small Private Online Course as a New Approach to Teaching Oncology: Development and Evaluation
A New Peer-Reviewed Journal with Focus on Technology, Innovation and Openess in Medical Education
- 28 February 2013
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 25 (4) , 121-126
Proposal for a predictive model of erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
To determine the risk factors for EDin men treated by prostate brachytherapy (PB) for localized prostate cancer and to propose a model to predict post-implant erectile function. Out of a series of 270 sexually active men treated by PB, 241 (89%) (mean age=66 years (range, 43-80)) accepted to participate in a mail-based study on erectile function. The risk factors for erectile dysfunction were determined by regression analysis and a predictive model was proposed. The performance of the model was determined in this population and subsequently verified in a population of 50 men treated by PB in another treatment center. The risk factors for ED after PB were age, the pre-implant IIEF score and prostate volume. In the studied population, the final model to predict a post-treatment IIEF-5 score, using these factors, had a sensitivity of 69% and a specificity of 68% associated to an area under the ROC curve (AUC) of 0.75. The same performance was obtained in another treatment center. Age, pre-implant IIEF-5 score and prostate volume may be used to predict post-implant erectile function in patients treated by PB.
- 28 February 2013
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 25 (4) , 121-126
Proposal for a predictive model of erectile function after permanent 125I prostate brachytherapy for localized prostate cancer
To determine the risk factors for EDin men treated by prostate brachytherapy (PB) for localized prostate cancer and to propose a model to predict post-implant erectile function. Out of a series of 270 sexually active men treated by PB, 241 (89%) (mean age=66 years (range, 43-80)) accepted to participate in a mail-based study on erectile function. The risk factors for erectile dysfunction were determined by regression analysis and a predictive model was proposed. The performance of the model was determined in this population and subsequently verified in a population of 50 men treated by PB in another treatment center. The risk factors for ED after PB were age, the pre-implant IIEF score and prostate volume. In the studied population, the final model to predict a post-treatment IIEF-5 score, using these factors, had a sensitivity of 69% and a specificity of 68% associated to an area under the ROC curve (AUC) of 0.75. The same performance was obtained in another treatment center. Age, pre-implant IIEF-5 score and prostate volume may be used to predict post-implant erectile function in patients treated by PB.
- 1 November 2009
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 75 (3) , 696-702
Basic Fibroblast Growth Factor-2/β3 Integrin Expression Profile: Signature of Local Progression After Chemoradiotherapy for Patients With Locally Advanced Non–Small-Cell Lung Cancer
- 1 November 2009
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 75 (3) , 696-702
Basic Fibroblast Growth Factor-2/β3 Integrin Expression Profile: Signature of Local Progression After Chemoradiotherapy for Patients With Locally Advanced Non–Small-Cell Lung Cancer
- 1 November 2001
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 61 (2) , 135-141
Trans-rectal ultrasonography (TRUS) with lipiodol injection for localization of the prostatic apex before radiotherapy planning
- 1 November 2001
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 61 (2) , 135-141
Trans-rectal ultrasonography (TRUS) with lipiodol injection for localization of the prostatic apex before radiotherapy planning
- 1 February 1991
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 20 (2) , 343-345
Radiosensitivity of jejunal mucosa after whole abdomen irradiation and CDDP pretreatment
- 1 February 1991
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 20 (2) , 343-345
Radiosensitivity of jejunal mucosa after whole abdomen irradiation and CDDP pretreatment